The Administrative Core (Admin Core) will be responsible for the oversight and daily functions of the SPORE and provide organizational leadership for the overall successful conduct of the program. It will provide organizational leadership and administrative support for all of the aspects of the SPORE, including coordination and communication between all investigators and committee members. It will provide scientific management, including ongoing management and scientific review of all projects and cores to ensure that the stated scientific goals of the SPORE are met. The Core has ultimate responsibility for the overall financial management of the budget and appropriate filing of budgetary information. It will organize regularly scheduled meetings and seminars, and provide commitment of SPORE investigators to attend the annual NCI Translational Science Meeting and other relevant workshops. The scheduling and organization of an annual UCLA Brain Cancer SPORE Symposium, including participation of the External Advisory Board, will be the responsibility of the Administrative Core. This core will oversee the administration of the SPORE Developmental Research and Career Enhancement Programs, while providing oversight of all the established policies for recruitment of women and minorities. It will be the liaison between the SPORE and the NCI-designated Jonsson Comprehensive Cancer Center, other UCLA academic and administrative bodies, NIH/NCI staff, IAB/EAB members, and patient advocacy groups. It will ensure that appropriate regulatory approvals are maintained and will complete necessary documentation with regulatory agencies. The Administrative Core will also ensure that data and resources are shared appropriately in order to promote intra- and inter-SPORE collaboration, including maintenance and updating of a UCLA Brain SPORE website. The brain tumor community at UCLA has been in existence for almost 20 years and has a track record of productivity. As such, the leadership of the Administrative Core of this SPORE is well-integrated in many ways to the higher administration levels of the institution.

Public Health Relevance

Core A: Administrative Core NARRATIVE The Administrative Core is necessary to coordinate all of the scientific and administrative activities within the SPORE. This UCLA Brain SPORE is designed to develop new, innovative, and more effective treatments for patients with brain tumors, and the Administrative Core will provide the organizational leadership and administrative support for the successful conduct of the SPORE. The proposed studies in the UCLA SPORE in Brain Cancer and the ultimate success of the translational investigations proposed herein will be a reflection of careful planning and integration of the research efforts by the Administrative Core leadership team.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA211015-02
Application #
9543447
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2018-08-01
Budget End
2019-07-31
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Li, Tie; Cox, Christopher D; Ozer, Byram H et al. (2018) D-2-Hydroxyglutarate Is Necessary and Sufficient for Isocitrate Dehydrogenase 1 Mutant-Induced MIR148A Promoter Methylation. Mol Cancer Res 16:947-960
Pope, Whitney B (2018) Brain metastases: neuroimaging. Handb Clin Neurol 149:89-112
Kepe, Vladimir; Scafoglio, Claudio; Liu, Jie et al. (2018) Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas. J Neurooncol 138:557-569
Magaki, Shino; Parks, Robyn; Vinters, Harry V et al. (2018) A 44-Year-Old Female with Familial Mediterranean Fever, Cardiomyopathy and End Stage Renal Disease. Brain Pathol 28:135-136
Gallaher, Sean D; Fitz-Gibbon, Sorel T; Strenkert, Daniela et al. (2018) High-throughput sequencing of the chloroplast and mitochondrion of Chlamydomonas reinhardtii to generate improved de novo assemblies, analyze expression patterns and transcript speciation, and evaluate diversity among laboratory strains and wild isolates. Plant J 93:545-565
Calais, Jeremie; Czernin, Johannes; Cao, Minsong et al. (2018) 68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning. J Nucl Med 59:230-237
Liau, Linda M; Ashkan, Keyoumars; Tran, David D et al. (2018) First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. J Transl Med 16:142
Ellingson, Benjamin M; Wen, Patrick Y; Cloughesy, Timothy F (2018) Evidence and context of use for contrast enhancement as a surrogate of disease burden and treatment response in malignant glioma. Neuro Oncol 20:457-471
Ellingson, Benjamin M; Abrey, Lauren E; Nelson, Sarah J et al. (2018) Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. Neuro Oncol 20:1240-1250
Majedi, Fatemeh S; Hasani-Sadrabadi, Mohammad Mahdi; Kidani, Yoko et al. (2018) Cytokine Secreting Microparticles Engineer the Fate and the Effector Functions of T-Cells. Adv Mater 30:

Showing the most recent 10 out of 91 publications